Burden of non-serious infections during biological use for rheumatoid arthritis.

<h4>Introduction</h4>Biologicals have become a cornerstone in rheumatoid arthritis (RA) treatment. The increased risk of serious infections associated with their use is well-established. Non-serious infections, however, occur more frequently and are associated with a high socioeconomic b...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296821&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296821&type=printable

Similar Items